Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orient EuroPharma (OEP) is a leading pharmaceutical company based in Taiwan with a significant presence across the Asia-Pacific region. The company operates through several business units, including prescription medicines, innovative medical products, nutrition and baby care, and dermo-cosmetics. OEP is known for its robust research and development capabilities, particularly in the areas of oncology, central nervous system disorders, and respiratory diseases. Through its subsidiary Orient Pharma, the company develops and manufactures a diverse portfolio of products, including innovative drug delivery systems and generic medications. OEP also maintains strategic partnerships with global pharmaceutical firms to license and commercialize advanced therapeutic solutions in Asian markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OOgroup.